Protease activation during nitric oxide-induced apoptosis: Comparison between poly(ADP-ribose) polymerase and U1-70kDa cleavage

European Journal of Pharmacology

Volumn 349, Issue 2-3, 1998, Pages 333-343

  Meßmer, Udo K ^a   Reimer, Dietrich M ^a   Brüne, Bernhard ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Apoptosis; Bcl 2; ICE like protease; Nitric oxide (NO); Poly(ADP ribose) polymerase

Indexed keywords

NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROTEIN P53; PROTEINASE; PROTEINASE INHIBITOR; S NITROSOGLUTATHIONE; SMALL NUCLEAR RIBONUCLEOPROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CONTROLLED STUDY; IN VITRO STUDY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; APOPTOSIS; ASPARTIC ACID; CELL LINE; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; MACROPHAGES; MICE; NITRIC OXIDE; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS C-BCL-2; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032557671     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00189-7     Document Type: Article

References (47)

1. Albina J.E., Martin B.-A., Henry W.L. Jr., Louis C.A., Reichner J.S. B cell lymphoma-2 transfected P815 cells resist reactive nitrogen intermediate-mediated macrophage-dependent cytotoxicity. J. Immunol. 157:1996;279-283.
2. Änggard E. Nitric oxide: mediator, murderer, and medicine. Lancet. 343:1994;1199-1206.
3. Armstrong R.C., Aja T., Xiang J., Gaur S., Krebs J.F., Hoang K., Bai X., Korsmeyer S.J., Karanewsky D.S., Fritz L.C., Tomaselli K.J. Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J. Biol. Chem. 271:1996;16850-16855.
4. Bradford M.M. A rapid and sensitive method for the quantification of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the estimation of deoxyribonucleic acid. Biochem. J. 62:1956;315-323.
6. Casciola-Rosen L.A., Miller D.K., Anhalt G.J., Rosen A. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J. Biol. Chem. 269:1994;30757-30760.
7. Casciola-Rosen L., Nicholson D.W., Chong T., Rowan K.R., Thornberry N.A., Miller D.K., Rosen A. Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J. Exp. Med. 183:1996;1957-1964.
8. Chinnaiyan A.M., Orth K., O'Rourke K., Duan H., Poirier G.G., Dixit V.M. Molecular ordering of the cell death pathway. J. Biol. Chem. 271:1996;4573-4576.
9. Chiu V.K., Walsh C.M., Liu C.-C., Reed J.C., Clark W.R. Bcl-2 blocks degranulation but not fas-based cell-mediated cytotoxicity. J. Immunol. 154:1995;2023-2032.
10. Darmon A.J., Bleackley R.C. An interleukin-1β converting enzyme-like protease is a key component of Fas-mediated apoptosis. J. Biol. Chem. 271:1996;21699-21702.
11. Eliasson M.J.L., Sampei K., Mandir A.S., Hurn P.D., Traystman R.J., Bao J., Pieper A., Wang Z.-Q., Dawson T.M., Snyder S.H., Dawson V.L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3:1997;1089-1095.
12. Enari M., Talanian R.V., Wong W.W., Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:1996;723-726.
13. Fraser A., Evan G. A licence to kill. Cell. 85:1996;781-784.
14. Gamen S., Marzo I., Anel A., Piñeiro A., Naval J. CPP32 inhibition prevents Fas-induced ceramide generation and apoptosis in human cells. FEBS Lett. 390:1996;233-237.
15. Ghibelli L., Maresca V., Coppola S., Gualandi G. Protease inhibitors block apoptosis at intermediate stages: a compared analysis of DNA fragmentation and apoptotic nuclear morphology. FEBS Lett. 377:1995;9-14.
16. Greidinger E.L., Miller D.K., Yamin T.-T., Casciola-Rosen L., Rosen A. Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett. 390:1996;299-303.
17. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E.A., Longthorne V.L., Culhane A.C., Williams G.T. Apoptosis: molecular regulation of cell death. Eur. J. Biochem. 236:1996;1-26.
18. Hart T.W. Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutathione. Tetrahedron Lett. 26:1985;2013-2016.
19. 2 in breast carcinoma cells. Oncogene. 10:1995;2297-2305.
20. Kaufmann S.H., Desnoyers S., Ottaviano Y., Davidson N.E., Poirier G.G. Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53:1993;3976-3985.
21. Kumar S., Harvey N.L. Role of multiple cellular proteases in the execution of programmed cell death. FEBS Lett. 375:1995;169-173.
22. Leist M., Single B., Künstle G., Volbracht C., Hentze H., Nicotera P. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 233:1997;518-522.
23. Mashima T., Naito M., Fujita N., Noguchi K., Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem. Biophys. Res. Commun. 217:1995;1185-1192.
24. Mashima T., Naito M., Kataoka S., Kawai H., Tsuruo T. Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem. Biophys. Res. Commun. 309:1995;907-915.
25. + content and p53 accumulation. Arch. Biochem. Biophys. 327:1996;1-10.
26. Meßmer U.K., Brüne B. Nitric oxide-induced apoptosis: p53-dependent and p53-independent signalling pathways. Biochem. J. 319:1996;299-305.
27. Meßmer U.K., Ankarcrona M., Nicotera P., Brüne B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett. 355:1994;23-26.
28. Meßmer U.K., Lapetina E.G., Brüne B. Nitric oxide induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C and protein kinase A activating compounds. Mol. Pharmacol. 47:1995;757-765.
29. Meßmer U.K., Reed J.C., Brüne B. Bcl-2 protects macrophages from nitric oxide-induced apoptosis. J. Biol. Chem. 271:1996;20192-20197.
30. Meßmer U.K., Reimer D.M., Reed J.C., Brüne B. Nitric oxide induced poly(ADP-ribose) polymerase cleavage in RAW 264.7 macrophage apoptosis is blocked by Bcl-2. FEBS Lett. 384:1996;162-166.
31. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
32. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
33. Nathan C., Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell. 78:1994;915-918.
34. Nicholson D.W., Ali A., Thornberry N.A., Vaillancourt J.P., Ding C.K., Gallant M., Gareau Y., Griffin P.R., Labelle M., Lazebnik Y.A., Munday N.A., Raju S.M., Smulson M.E., Yamin T.-T., Yu V.L., Miller D.K. Identification and inhibition of ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 376:1995;37-43.
35. Oberhammer F.A., Wilson J.W., Dive C., Morris I.D., Hickman J.A., Wakeling A.E., Walker P.R., Sikorska M. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:1993;3679-3684.
36. Orth K., Chinnaiyan A.M., Garg M., Froelich C.J., Dixit V.M. The CED-3/ICE-like protease Mch2 is activated during apoptosis and cleaves the death substrate lamin A. J. Biol. Chem. 271:1996;16443-16446.
37. Orth K., O'Rourke K., Salvesen G.S., Dixit V.M. Molecular ordering of apoptotic mammalian CED-3/ICE-like proteases. J. Biol. Chem. 271:1996;20977-20980.
38. Patel T., Gores G.J., Kaufmann S.H. The role of proteases during apoptosis. FASEB J. 10:1996;587-597.
39. Quan L.T., Tewari M., O'Rourke K., Dixit V., Snipas S.J., Poirier G.G., Ray C., Pickup D.J., Salvesen G.S. Proteolytic activation of the cell death protease YAMA/CPP32 by granzyme B. Proc. Natl. Acad. Sci. USA. 93:1996;1972-1976.
40. Schlegel J., Peters I., Orrenius S., Miller D.K., Thornberry N.A., Yamin T.-T., Nicholson D.W. CPP32/apopain is a key interleukin 1β converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1996;1841-1844.
41. Schulze-Osthoff K., Walczak H., Dröge W., Krammer P.H. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol. 127:1994;15-20.
42. Shimizu S., Eguchi Y., Kamiike W., Matsuda H., Tsujimoto Y. Bcl-2 expression prevents activation of the ICE protease cascade. Oncogene. 12:1996;2251-2257.
43. Song Q., Lees-Miller S.P., Kumar S., Zhang N., Chan D.W., Smith G.C.M., Jackson S.P., Alnemri E.S., Litwack G., Khanna K.K., Lavin M.F. DNA-dependent protein kinase catalytic subunit: a target for an ICE-like protease in apoptosis. EMBO J. 15:1996;3238-3246.
44. Thornberry N.A., Bull H.G., Calaycay J.R., Chapman K.T., Howard A.D., Kostura M.J., Miller D.K., Molineaux S.M., Weidner J.R., Aunins J.et al. A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes. Nature. 356:1992;768-774.
45. Wang Z.-Q., Stingl L., Morrison C., Jantsch M., Los M., Schulze-Osthoff K., Wagner E.F. PARP is important for genomic stability but dispensable in apoptosis. Genes Dev. 11:1997;2347-2358.
46. Wright S., Wei Q., Zhong J., Zheng H., Kinder D., Larrick J. Purification of a 24-kDa protease from apoptotic tumor cells that activates DNA fragmentation. J. Exp. Med. 180:1995;2113-2123.
47. Wright S.C., Zheng H., Zhong J. Tumor cell resistance to apoptosis due to a defect in the activation of sphingomyelinase and the 24 kDa apoptotic protease (AP24). FASEB J. 10:1996;325-332.